Histone Acetylation as a Potential Therapeutic Target in Motor Neuron Degenerative Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|28|5093-5104

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.28, 2013-04, pp. : 5093-5104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Skeletal Muscle in Motor Neuron Diseases: Therapeutic Target and Delivery Route for Potential Treatments

By  

Current Drug Targets, Vol. 11, Iss. 10, 2010-10 ,pp. : 1250-1261

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: Therapeutic Agents and Research Tools for Deciphering Motor Neuron Diseases

By  

Current Medicinal Chemistry, Vol. 15, Iss. 13, 2008-06 ,pp. : 1263-1273

Bentham Science Publishers

Access to resources Recommend Favorite

Cell to Cell Spreading of Misfolded Proteins as a Therapeutic Target in Motor Neuron Disease

By  

Current Medicinal Chemistry, Vol. 21, Iss. 31, 2014-10 ,pp. : 3508-3534

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylation and Motor Neuron Degeneration

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 3, 2010-07 ,pp. : 279-284

Bentham Science Publishers

Access to resources Recommend Favorite

Fas ligand: a potential target for therapeutic immune modulation in transplantation and inflammatory diseases

By O'Connell J.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 4, 1999-12 ,pp. : 503-512

Informa Healthcare

Access to resources Recommend Favorite